Voluntary announcement - phase ib clinical trial of jmt206 injection for weight management in adult patients with overweight or obesity officially initiated at the first study centre in china
Filed with HKEX · Stock code 1093 ·
6ix hasn’t read this filing yet.
View original source (HKEXnews)Company analysis
Earlier from Cspc Pharmaceutical
- Voluntary announcement - recombinant herpes zoster vaccine (sys6052) obtains clinical trial approval in the U.S.
- Voluntary announcement - sys6077 injection obtains clinical trial approval in china
- Alphamab Oncology Announces the Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 as Neoadjuvant Treatment for Breast Cancer Has Met the Primary Endpoint
- Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 and Chemotherapy as Adjuvant Treatment of Breast Cancer